Europe

Europe is the home of The Union’s headquarters in Paris, France. Through our offices in Europe, The Union works at a strategic level to influence global health policy. 

You are here:

Europe

Published on

Updated:

Health Challenges in Europe

229,000

TB incidence in 2022

62,000

drug-resistant TB incidence in 2022

24,300

deaths from TB in 2022

The Union's Offices

The Union’s headquarters in Paris is the global cornerstone of the organisation, taking on a coordinating role, sets policy and provides financial oversight of the organisation. The Union Switzerland Office, based in Geneva, acts as the political convenor for The Union, working at a strategic level to influence global health policy through high-level discussion and partnership.

The Union Switzerland Office

Category: Laman asas

Avenue Guiseppe Motta 31/33
1202 Geneve
Switzerland

Members of The Union Europe Region

The Union is divided into seven regions to provide a platform for addressing lung health and related issues from a regional perspective. This structure offers members opportunities to network with colleagues who face the same regional challenges and contributes to The Union's deep understanding of local issues. 

The Union Europe Region is made up of individuals and organisations.

Members in action

Europe members pioneer regional focus at Union World Conferences

Members in Europe initiated the first dedicated region Scientific Track, held at the Union World Conference on Lung Health. The sessions, developed in partnership with members of The Union’s Europe Region, shared experiences and challenges that are specific to the continent and invited delegates to focus on TB and lung health concerns that are particularly pressing in Europe.

UNION NEWS FROM THE Europe REGION

Compliance with intermittent preventive malaria treatment in pregnancy at a tertiary hospital in Sierra Leone

Published on

In this article, part of the TB, HIV and Malaria Series to be published in the Q2 issue of PHA, the authors examine uptake of intermittent preventive treatment in pregnancy in Sierra Leone, showing low compliance with the recommended minimum of three doses, largely associated with insufficient antenatal care contacts.

Mapping Malaria Hotspots through Spatial and Spatio-Temporal Analysis in Sierra Leone, 2021-2024

Published on

In this article part of the TB, HIV and Malaria Series to be published in the Q2 issue of PHA, the authors analyse the spatial and temporal distribution of malaria in Sierra Leone, identifying persistent hotspots and no significant association with rainfall. The findings highlight the need for targeted, subnational interventions to address persistent hotspots.

Parenteral artesunate compliance and hospital outcomes in children under-five with suspected severe malaria in Sierra Leone

Published on

In this article, part of the TB, HIV and Malaria Series to be published in the Q2 issue of PHA, the authors assess adherence to national severe malaria management guidelines in children under five in Sierra Leone and its association with hospital outcomes, highlighting suboptimal artesunate dosing and related adverse outcomes.